RayzeBio, Inc.
RYZBDelisted Feb 26, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001825367
RayzeBio, Inc. was delisted on Feb 26, 2024; its insiders filed their last Form 4 on Feb 28, 2024; 107 institutions reported holding it in 13F filings for Q4 2023, worth $3.40B in total; superinvestors Viking Global Investors and HHLR Advisors (Hillhouse) held it.
Q4 2023 vs. Q3 2023
How the institutions holding RayzeBio, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 68 | 107 | +39 |
| Shares | 54.2M | 54.8M | +577.6K (+1.1%) |
| Value | $1.20B | $3.40B | +$2.20B (+183.2%) |
New holders (59)
Institutions that held RayzeBio, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (20)
Institutions that held RayzeBio, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Artal Group S.A. | 555,556 | $12.3M |
| Avidity Partners Management LP | 500,000 | $11.1M |
| Braidwell LP | 277,778 | $6.17M |
| Millennium Management LLC | 213,757 | $4.75M |
| Hood River Capital Management LLC | 84,111 | $1.87M |
| LMR Partners LLP | 77,459 | $1.72M |
| TD Asset Management Inc | 72,610 | $1.61M |
| Maven Securities LTD | 59,835 | $1.33M |
| Citadel Advisors LLC | 54,009 | $1.20M |
| Discovery Capital Management, LLC | 50,000 | $1.11M |
| Greenland Capital Management LP | 48,737 | $1.08M |
| RTW Investments, LP | 46,300 | $1.03M |
| Point72 Middle East FZE | 45,275 | $1.01M |
| Two Sigma Investments, LP | 38,500 | $854.7K |
| Monashee Investment Management LLC | 27,500 | $610.5K |
| Alyeska Investment Group, L.P. | 25,000 | $555.0K |
| Soros Fund Management LLCSuperinvestorSoros Fund Management | 20,000 | $444.0K |
| Squarepoint Ops LLC | 16,653 | $369.7K |
| Walleye Capital LLC | 14,847 | $329.6K |
| Norges Bank | 10,000 | $222.0K |